Plasma-reduced platelet concentrates are commonly administered to prevent febrile transfusion reactions and to avoid fluid overload in neonates. Because little is known about the influence of centrifugation and resuspension on functional aspects of platelets, we examined the effects of plasma-reduction on platelet aggregation and platelet-dependent thrombin generation. Our results show that plasma reduction and resuspension of the platelet pellet in saline or plasma results in a significant reduction in platelet aggregation to a combination of the platelet agonists adenosine diphosphate and epinephrine (p < 0.001). In contrast, when a combination of the more Platelet concentrate (PC) transfusion is a critical element in the supportive care of patients undergoing intensive chemotherapy, stem cell transplantation, and in patients in whom thrombocytopenia develops secondary to consumptive coagulopathy. The most frequent complication of PC transfusion is the development of rigors and fever. This complication results in the interruption of the transfusion, testing to exclude an infectious etiology for the reaction, and is a considerable cause of patient discomfort and suffering. Febrile reactions have been attributed to the pres-
potent agonists collagen and thrombin was used, platelet aggregation was maintained. Likewise, no decline was observed in plateletdependent thrombin generation as measured by the functional prothrombinase assay or Annexin V binding. We conclude that centrifugation and resuspension of platelets to render the concentrate plasma-free, as a routine procedure in blood banking, variably affects in vitro platelet aggregability but does not significantly affect plateletdependent thrombin generation. Key Words: Platelet concentrates-Plasma-depletion-Aggregation-Phosphatidylserine expression-Prothrombinase. ence of passenger leukocytes in the PC bag (1) , and more recently to the presence of a variety of pyrogenic cytokines including interleukin 13 and tumor necrosis factor secreted by leukocytes into the plasma in the PC bag (2) . The causative role of the plasma supernatant in febrile reactions was demonstrated in a seminal paper by Heddle and associates (3) . In her study, the transfusion of the plasma supernatant of stored PCs induced febrile reactions in patients, while the transfusion of the remaining platelets from the same unit devoid of the plasma, did not. Because of this finding, it has become common practice in many blood banks to prepare a PC that is rendered free of plasma immediately before transfusion and is transfused either in a small volume of residual plasma or resuspended in isotonic saline. A recommended protocol for this procedure has been published (4) . However, little is known regarding the extent to which the process of plasma depletion with or without saline resuspension affects various aspects of platelet function.
The process of preparation of PCs and their storage results in a number of alterations on normal platelet structure and function. Together these changes are referred to as the platelet storage lesion (5) . Among the changes that occur during PC preparation are the development of defects in platelet aggregability (6) and abnormal platelet-dependent thrombin generation (7) . In this study we examine the effect of plasma reduction of PCs on these two aspects of platelet function using three different methods: the measurement of agonist-induced platelet aggregation, measurement of platelet-dependent thrombin generation using the prothrombinase assay, and measurement by flow cytometry of the expression of the anionic phospholipid, phophatidylserine, which is important for platelet-dependent thrombin generation.
MATERIALS AND METHODS

Platelet Concentrates
Platelet concentrates were prepared from platelet-rich plasma (PRP) using standard blood bank protocols (8) from volunteer donors meeting Israeli national blood service criteria. In brief, whole blood was collected into triple packs (Travenol Laboratories, Ashdod, Israel) containing citrate-phosphate-dextrose-adenosine (CPDA-1). The packs were centrifuged for 3 minutes at 2,000 g in a Sorvall RC-3 centrifuge. The supernatant was transferred to one of the satellite bags and centrifuged for 5 minutes at 5,000 g. The platelet poor plasma supernatant was transferred to another pack and approximately 50 mL of plasma remained for resuspension of the platelet pellet. The platelets were left undisturbed for 90 minutes and were then resuspended manually. They were then stored at room temperature on a flat agitator (LPR-3, Melco Engineering Corp., Glendale, CA) for up to 5 days.
The contents of each platelet concentrate were divided to three parts prior to the performance of the experiments. One third was not treated further and served as a control, one third was centrifuged at 2,000 g for 10 minutes, the platelet-poor plasma (PPP) supernatant discarded, and the platelet pellet resuspended in 20 cc of isotonic saline solution, and one third was centrifuged at 2,000 g for 10 minutes, the majority of the PPP discarded and the platelet pellet resuspended in 5 to 10 mL of autologous PPP. Before the resuspension phase, the platelets were agitated for 90 minutes on a flat agitator (LPR-3, Melco Engineering Corp., Glendale, CA) and were gently manually agitated until a clear suspension was obtained.
Aggregation Studies
Aggregation studies were performed on 21 platelet concentrates that had been stored for 3 days (n=3), 4 days (n=5), or 5 days (n=13). PRP samples were diluted using PPP to a platelet count of 300 x 109/L using a Technicon Hi automated analyzer. Leukocyte contamination of the platelet samples was not assessed. Platelet aggregation studies were performed using a Platelet Aggregation Chromogenic Kinetic System (PACKS-4, Helena Laboratories, Beaumont, TX). Agonists were added to the samples in combination to achieve final concentrations as follows: adenine diphosphate (ADP) 10,utM and epinephrine 150,M and collagen (equine tendon species) and thrombin at 5 Ag/mL and 0.5 U/mL, respectively. The agonists were all obtained from Helena Haemostasis Systems (Sunderland, UK) apart from thrombin that was obtained from Dade Behring (Marburg, Germany).
Preparation of Platelets for the Prothrombinase Assay and for Annexin V Binding PRP platelets were diluted in a dilution buffer to a final concentration of 1 x 106/mL. The buffer constituents were NaCl 137 mM, KCl 2.7 mM, MgCl2 1.0 mM, HEPES 3.5 mM, NaH2PO4 3 mM, glucose 5.5 mM, and fatty acid free albumin 0.35%. NaOH was added to titrate the PH to 7.2.
Prothrombinase Assay
The prothrombinase assay was performed on 15 platelet concentrates that had been stored for 1 day (n=l), 2 days (n=2), 3 days (n=4), 4 days (n=3), or 5 days (n=5). The methods were adapted from a previously published assay for the measurement of phospholipid-dependent thrombin formation (9) . Fresh plasma from normal donors served as a source of factors V, X, and prothrombin and was diluted in Tris Buffered Saline (TBS) in a 1:50 ratio. Activated factor X was obtained by the addition of 1 ,ug/mL dilute Russell viper venom (dRVV) (Diagnostica Stago, Asnieres, France). The reaction mixture consisted of 200 AL diluted plasma, 100 AL of 1:100 dRVV at a concentration of 1 Aug/mL, 100 ,uL PRP-derived platelets, and 250 AL CaCl2 0.05M.
Incubation was performed at 37°C for 10 minutes and the reaction was stopped by the addition of 10 ,uL of EDTA. 500 AL of a 1.9 mM chro-mogenic substrate at a concentration of 1.25 mg/mL (Chromozyme TH; Boehringer Mannheim, Germany) was added and the reaction supernatant was transferred immediately to a spectrophotometer (Milton Roy, Spectronic 1201) and light absorption was read at a wavelength of 405 nm. Thrombin generation was determined from an optical density curve standardized for the current experimental conditions.
Annexin V Assay
Annexin V binding was measured in 25 platelet concentrates that had been stored for 3 days (n=6), 4 days (n=5), or 5 days (n= 14). Fifty microliters of diluted PRP-derived platelets were incubated with 5 ,utL fluoresceine-labeled annexin V (Apoptosis detection Kit, R&D, Minneapolis, MN) and its binding buffer (50 ,uL) for 10 minutes at room temperature. Thereafter 450 AL annexin buffer (Apoptosis detection Kit, R&D, Minneapolis, MN) was added and the reaction mixture analyzed in an Epics XL-MCL II flow cytometer (Eastronics, UK). Forward-scatter and orthagonal-scatter detectors were set to a logarithmic scale for detection of platelets. Platelets were identified by characteristic forward and orthagonal fight scatter. After identification of platelets by light scatter gating, binding of labeled annexin V was determined by analyzing 10,000 individual platelets for FITC fluo- Statistical Analyses GraphPad Prism® version 3.0 software for Windows (San Diego, CA) was used for performing statistical analyses. All data passed the Kolgomorov-Smirnov normality test and a oneway analysis of variance (ANOVA) test was used to compare data.
RESULTS
Aggregation Studies
Platelet aggregation in the presence of a combination of collagen and thrombin was measured in 28 PCs. Maximal aggregation was 58.9 + 11.9% (mean ± SE) in the control group, 74.2 ± 7.3% in the saline resuspension group and 51.1 ± 9.8% in the plasma resuspension group, respectively (p=0.3). When the 4-and 5-day-old platelets were considered as a separate subgroup, the corresponding values were 54.22 ± 17%, 70.8 12.7%, and 48.5 ± 13.3% (p=0.5) ( Fig. 1) . Fourteen Annexin V binding was measured in 33 PCs. In the control platelets, mean + SE values of 18.7 + 2.3% were obtained. In the saline resuspension group annexin V binding was 15.5 ± 2.6% and in the plasma-resuspended platelets it was 19.1 ± 3.0% (p=0.6). When the 4 and 5 day-old platelets were considered as a separate subgroup, the corresponding values were 23.9 + 3.0%, 18.2 ± 3.4% and 22.3 ± 3.7% (p=0.5) ( Fig. 3) .
Platelet-Dependent Thrombin Generation
The prothrombinase assay was performed on 15 PCs and mean ± SE thrombin levels were 1.7 ± 0.3 ,u/mL in the control group, 0.9 ± 0.2 ,/mL in the saline-resuspension group, and 1.6 ± 0.7 ut/mL in the plasma-resuspension group (p=0.4).
Corresponding results in day 4 and 5 platelets were 1.4 ± 0.6 ,/mL, 0.6 ± 0.3 ,u/mL, and 1.7 ± 1.2,u/mL (p= 0.6) ( Fig. 4) .
DISCUSSION
Febrile reactions complicate up to 30% of platelet transfusions (10) . When leukocyte filtration is performed before storage of platelet concentrates, the rate of febrile reactions may be reduced to 10% (11) . It has been shown that a sig-nificant number of the febrile reactions result from soluble cytokines present in the plasma supernatant of the PC. A method for diminishing cytokine-mediated reactions that has been shown to be useful is the removal of the plasma supernatant from the PC immediately before issuing the PC from the blood bank. This is achieved by further centrifugation of the PC and resuspension of the unit in isotonic saline or in a small volume (5-10 mL) of autologous plasma supernatant. Plasma-reduced PCs are also frequently administered to neonates because of the necessity to provide small volume platelet transfusions. In the current study, we investigated whether the generation of plasma-depleted PCs yielded a platelet product of inferior functional capacity, focusing on the effects of plasma depletion on platelet aggregation and the exposure of PS on the external aspect of the platelet membrane and concomitant thrombin generation.
Our results show that platelet aggregation to a combination of collagen and thrombin is preserved when plasma depletion is performed and the platelet pellet resuspended in either saline or autologous plasma. We studied combinations of agonists rather than single agents because it is known that while aggregation in response to single agonists may be very weak or absent in stored platelets, their response to combinations of agonists may be restored (12) . Aggregation was not affected even when platelets that had been stored for 4 or 5 days were analyzed separately. This finding is significant because platelet aggregation declines progressively during storage (13) , and it is specifically in older PCs that the highest concentrations of cytokines are found, and thus it would be expected that plasma depletion would most beneficial in when performed on these units. When ADP and epinephrine were used together as agonists, aggregation declined significantly after plasma depletion, whether the resuspended in saline or in plasma. The mechanism of the reduced aggregation is uncertain but may relate to shedding or internalization of platelet surface membrane ADP or epinephrine receptors. There was marked variation in platelet aggregation to both sets of agonists in all groups included the control group that was not plasma-reduced. This phenomenon is well recognized and reflects the varible and unpredictable nature in which agonist-induced aggregation is affected by the production and storage of PCs. For this reason, aggregation studies are not recommended for monitoring the quality of platelet products dispensed from the blood bank (13) .
Platelet-dependent thrombin generation did not diminish after plasma depletion and this finding correlated with a constant level of annexin V binding as detected by flow cytometry. This implies that the expression of the anionic phospholipid phosphatidylserine on the outer platelet membrane is not affected by plasma depletion and resuspension in either saline or plasma.
Our in vitro findings are consistent with the clinical observations of Heddle and associates (3) . They reported that the infusion of plasmareduced PCs did not result in poorer control of bleeding than was expected clinically. However, in view of the highly variable response to platelet transfusion generally, and the difficulty that exists in accurately assessing in vivo platelet survival, it would be necessary to perform platelet survival studies using radiolabelled platelets before concluding that plasma-reduced PCs are equal in efficacy to unmanipulated PCs. If this were found to be the case, then plasma-reduced PCs should be considered the product of choice in patients with a history of febrile reaction to platelet transfusion or when older (3-5 day old) PCs are transfused.
